Cervical cancer and human papilloma virus vaccination: gap and barriers
Keywords:HPV vaccination, Cervical cancer, Indian Academy of Paediatrics Committee
Cervical cancer, which is mostly caused by infection with the human papillomavirus (HPV), is the second most common malignancy in women worldwide and the main illness affecting Indian women. It has been demonstrated that many developing countries lack basic information and health-seeking behaviours, necessitating the need for an effective awareness and immunization programme. For public health, the HPV vaccine is essential. For all females who can afford it, the Indian Academy of Paediatrics Committee on Immunization (IAPCOI) suggests administering the HPV vaccine. Females as young as 9 years old and those who have not received all recommended vaccinations between the ages of 13 and 26 can receive vaccinations. Cervical cancer can be prevented in a number of ways, however vaccination is currently the most effective strategy. The most effective means of preventing cervical cancer include HPV vaccination and routine cervical screening. Before beginning this chemoprophylaxis against cervical cancer, parents and caregivers of the child must receive education regarding HPV vaccine. In order to mobilise the scientific, public health, and civil society communities to adopt the vaccination policy, gaps and challenges to HPV vaccination access and delivery must be addressed.
Shankar A, Roy S, Rath GK, Chakraborty A, Kamal VK, Biswas AS. Impact of cancer awareness drive on generating awareness of and improving screening for cervical cancer: A study among school teachers in India. J Glob Oncol. 2018;4:1-7.
Shankar A, Roy S, Rath GK, Kamal VK, Kharade V, Sandeep K. Carcinoma uterine cervix: Evolving trends and Impact of national cancer control Program in India. Ind J Soc Prev Rehab Onc. 2017;1:16-22.
International Agency for Research on Cancer. Globocan; 2020. https://gco.iarc.fr/. Accessed 29 April 2021.
Schiffman M, Castle PE, Jeronim J, Rodrigue AC, Wacholde S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
Rastogi A. Human papillomavirus (HPV) infection and cervical cancer. NHP. Published by Zahid. https://www.nhp.gov.in/disease/communicable-disease/human-papillomavirus-hpv-infection-and-cervical-cancer. Accessed 8 April 2016.
Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: status and current concepts. Indian J Med Res. 2018;148(6):687–96.
Braaten KP, Laufer MR. Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine. Rev Obstet Gynecol. 2008;1:2–10
Rashid S, Labani S, Das BC. Knowledge, awareness and attitude on HPV, HPV vaccine and cervical cancer among the college students in India. PloS One. 2016;11:e0166713
Singhal T. Indian Academy of Pediatrics Committee on Immunisation (IAPCOI) - Consensus Recommendations on Immunization 2008. Indian Pediatr. 2008;45:635–48.
Chawla PC, Chawla A, Chaudhary S. Knowledge, attitude & practice on human papillomavirus vaccination: a cross-sectional study among healthcare providers. Indian J Med Res. 2016;144:741–9.
Maggi R. Assessing breast and cervical cancer in India: a literature review; 2018.
Hariprasad R, Babu R, Arora S, Mehrotra R. Capacity building in cancer screening using ECHO (extension for community healthcare outcomes): innovative and cost-effective model. J Glob Oncol. 2018;4(Supplement 2):160s–160s.
Rajaraman P, Anderson BO, Basu P, Belinson JL, Cruz AD, Dhillon PK, et al. Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015;16(7):e352–61.
Sivaram S, Majumdar G, Perin D, Nessa A, Broeders M, Lynge E, et al. Population-based cancer screening programs in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India. Lancet Oncol. 2018;19(2):e113–22.
Salaria S. Focus on Sikkim model to check cervical cancer. 2018. https://timesofindia.indiatimes.com/ city/noida/focus-on-sikkimmodel-to-check-cervical-cancer/articleshow/65600408.cms. Accessed 29 April 2021.
Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012;33:7-12.
Strohl AE, Mendoza G, Ghant MS, Cameron KA, Simon MA, Schink JC, et al. Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women. American Journal of Obstetrics and Gynecology. 2015;212(1):65.e1-65.e5.
Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, Smith JS. Potential Barriers to HPV Vaccine Provision Among Medical Practices in an Area with High Rates of Cervical Cancer. Journal of Adolescent Health. 2008;43(4Suppl):S61-7.
Krawczyk A, Perez S, King L, Vivion M, Dubé E, Rosberger Z. Parents’ decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results. Hum Vaccin Immunother 2015;11(2):330–6.
Nodulman JA, Starling R, Kong AS, Buller DB, Wheeler CM, Woodall WG. Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs. J Sch Health. 2015;85(5):289–98.
Gargano LM, Herbert NL, Painter JE, Sales JM, Vogt TM, Morfaw C, et al. Development, theoretical framework, and evaluation of a parent and teacher-delivered intervention on adolescent vaccination. Health Promot Pract. 2014;15(4):556–67.